This Article Free upon publication Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lopaschuk, G. D. Articles by Stanley, W. C. Search for Related Content PubMed PubMed Citation Articles by Lopaschuk, G. D. Articles by Stanley, W. C. Related Collections Biochemistry and metabolism Energy metabolism Ischemic biology - basic studies Type 2 diabetes

(Circulation Research. 2007;101:335.)
© 2007 American Heart Association, Inc.

Review

Cardiac Energy Metabolism in Obesity

Gary D. Lopaschuk, Clifford D.L. Folmes, William C. Stanley

From the Cardiovascular Research Group (G.D.L., C.D.L.F.), University of Alberta, Edmonton, Canada; and Division of Cardiology (W.C.S.), Department of Medicine, University of Maryland, Baltimore.

Correspondence to Dr Gary D. Lopaschuk, 423 Heritage Medical Research Center, University of Alberta, Edmonton, Alberta, T6G 2S2, Canada. E-mail gary.lopaschuk{at}ualberta.ca

This Review is part of a thematic series on the Pathobiology of Obesity, which includes the following articles:

Adipose-Derived Stem Cells for Regenerative Medicine

Cardiac Energy Metabolism in Obesity

Cardiovascular Risk in Obesity: Mechanisms of Leptin Signaling and Leptin Resistance

Lipid Disorders and the Metabolic Syndrome

Adiponectin as a Cardiovascular Protectant
Gary Lopaschuk Guest Editor

Obesity results in marked alterations in cardiac energy metabolism, with a prominent effect being an increase in fatty acid uptake and oxidation by the heart. Obesity also results in dramatic changes in the release of adipokines, such as leptin and adiponectin, both of which have emerged as important regulators of cardiac energy metabolism. The link among obesity, cardiovascular disease, lipid metabolism, and adipokine signaling is complex and not well understood. However, optimizing cardiac energy metabolism in obese subjects may be one approach to preventing and treating cardiac dysfunction that can develop in this population. This review discusses what is presently known about the effects of obesity and the impact adipokines have on cardiac energy metabolism and insulin signaling. The clinical implications of obesity and energy metabolism on cardiac disease are also discussed.

Key Words: fatty acid oxidation • adiponectin • leptin • malonyl–coenzyme A • PPAR • glycolysis

This article has been cited by other articles:

				M. R. Martins, A. K. G. Vieira, E. P. G. de Souza, and A. S. Moura Early overnutrition impairs insulin signaling in the heart of adult Swiss mice J. Endocrinol., September 1, 2008; 198(3): 591 - 598. [Abstract] [Full Text] [PDF]

				S. Hammer, R. W. van der Meer, H. J. Lamb, H. H. de Boer, J. J. Bax, A. de Roos, J. A. Romijn, and J. W. A. Smit Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus Am J Physiol Endocrinol Metab, September 1, 2008; 295(3): E714 - E718. [Abstract] [Full Text] [PDF]

				R. Harmancey, C. R. Wilson, and H. Taegtmeyer Adaptation and Maladaptation of the Heart in Obesity Hypertension, August 1, 2008; 52(2): 181 - 187. [Full Text] [PDF]

				D. J. Chess and W. C. Stanley Role of diet and fuel overabundance in the development and progression of heart failure Cardiovasc Res, July 15, 2008; 79(2): 269 - 278. [Abstract] [Full Text] [PDF]

				L. Bertrand, S. Horman, C. Beauloye, and J.-L. Vanoverschelde Insulin signalling in the heart Cardiovasc Res, July 15, 2008; 79(2): 238 - 248. [Abstract] [Full Text] [PDF]

				G. S. Getz and C. A. Reardon Nutrition and Cardiovascular Disease Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2499 - 2506. [Abstract] [Full Text] [PDF]